Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Is This The Year R&D Tax Credits Become Permanent?

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate Finance Committee Chairman Hatch’s top priority for the year is to develop legislation reforming the tax code. He forms five bipartisan committee working groups to develop and submit legislative recommendations by May.

You may also be interested in...



Obamacare’s Brand Drug Tax Would Be Repealed Under GOP’s ‘Replace’ Proposal

Industry hasn’t publicly opposed the tax, which it negotiated as part of the creation of the Affordable Care Act.

Comprehensive Tax Reform Touted To Industry By Republican Lawmakers

Republican leaders speaking at the Medical Device Manufacturers Association meeting this month say they are confident that broad-based tax reform can be achieved this year, and that it will be a boon to the device industry.

R&D Tax Credit Linked To Closing Foreign Tax Loopholes In Obama Plan

The Obama administration’s latest pitch for making permanent the research and development tax credit continues to tie the benefit to “ending unfair overseas tax breaks.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS077823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel